| Breakdown | TTM | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 220.66B | 227.85B | 221.88B | 201.03B | 189.03B | 190.69B |
| Gross Profit | 40.66B | 44.80B | 38.93B | 28.53B | 23.99B | 25.58B |
| EBITDA | 27.77B | 30.71B | 26.86B | 16.57B | 428.00M | 14.68B |
| Net Income | 21.04B | 18.48B | 19.89B | 7.94B | -6.91B | 6.68B |
Balance Sheet | ||||||
| Total Assets | 287.79B | 317.82B | 293.90B | 280.54B | 272.51B | 279.73B |
| Cash, Cash Equivalents and Short-Term Investments | 44.17B | 53.25B | 42.34B | 36.34B | 37.03B | 35.06B |
| Total Debt | 4.05B | 688.00M | 480.00M | 322.00M | 382.00M | 544.00M |
| Total Liabilities | 58.56B | 69.99B | 64.30B | 66.62B | 70.44B | 63.39B |
| Stockholders Equity | 226.17B | 244.27B | 226.57B | 211.10B | 199.44B | 213.23B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 24.61B | 17.22B | 10.34B | 2.10B | 6.30B |
| Operating Cash Flow | 0.00 | 29.15B | 22.75B | 13.72B | 6.18B | 7.97B |
| Investing Cash Flow | 0.00 | -7.09B | -11.53B | -6.10B | 4.84B | -4.33B |
| Financing Cash Flow | 0.00 | -12.99B | -7.64B | -7.32B | -7.51B | -8.52B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥262.06B | 12.19 | 7.43% | 2.78% | 2.69% | -6.90% | |
78 Outperform | ¥1.40T | 12.95 | 14.94% | 2.00% | 10.44% | 50.36% | |
78 Outperform | ¥685.36B | 12.93 | ― | 2.15% | 0.46% | 38.67% | |
76 Outperform | ¥333.97B | 12.00 | 8.70% | 2.28% | 3.94% | 34.77% | |
76 Outperform | ¥97.86B | 13.41 | ― | 4.38% | -5.06% | -2.68% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |